Kivu Biosciences
Biotechnology company developing novel therapeutics for neurodegenerative diseases using innovative biological approaches to address unmet medical needs.
Website
https://www.kivubio.comLocation
Boston, Massachusetts, USA
Founded
2021
Investors
1
Categories
biotech, therapeutics, neurodegenerative-disease, neuroscience
Notes
Kivu Biosciences is a biotechnology company focused on developing treatments for neurodegenerative diseases. The company is working to address the significant unmet medical need in conditions such as Alzheimer's disease, Parkinson's disease, and other neurological disorders that currently lack effective disease-modifying treatments.
Backed by Novo Holdings, Kivu Biosciences is pursuing novel approaches to tackle the complex biology underlying neurodegenerative conditions.
Team
- Information on leadership team pending further research
Additional Research Findings
- Founded around 2021
- Headquartered in the Boston area
- Investor: Novo Holdings
- Focus on neurodegenerative disease treatments
- Targeting conditions with significant unmet medical need
- Part of the growing neuroscience therapeutics sector
Sources
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| Novo Holdings | Hellerup, Denmark | biotech-focused | seedseries-a+3 | 13 |